H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

May 27, 2026 6:44 AM

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating and $125.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found